期刊文献+

复方倍他米松局部注射控制性治疗婴幼儿真性血管瘤 被引量:4

The controllable therapy of infantile hemangioma by local injection with compound betamethasone preparation (Diprospan )
原文传递
导出
摘要 目的探讨局部注射得保松(复方倍他米松注射液)治疗婴幼儿真性血管瘤的疗效。方法本组患者25例,瘤体面积1cm×1cm~8cm×8cm。初次治疗年龄为1~7个月。根据瘤体大小,初次注射得保松剂量1~2ml,以注射用水1~2ml稀释,在瘤体顶部和边缘向瘤体中心注射3~5针,共2~4ml,注射后每月随访一次。如瘤体持续消退,则无须再次注射;如瘤体有再次生长扩大的趋势,需要重复注射。随访至1岁后,改为不定期随访。结果①治疗后1个月,瘤体变柔软、平坦,颜色变为暗红色,大部分瘤体从中心部分开始消退。②治疗后2个月,部分较小瘤体基本消退;部分较大瘤体持续消退,可继续观察;少部分瘤体可在边缘再次增生,需要再次注射。③从初次就诊至1岁,需要1—3次治疗,大部分瘤体基本消退,少部分体积较大的瘤体也明显萎缩。部分患者随访至2岁,瘤体外观平坦,无纤维脂肪增生所致的局部肥大,仅遗留局部毛细血管扩张。④治疗后短期可见短暂的、可逆的局部皮肤萎缩,无其他并发症。结论复方倍他米松注射液用于局部早期真性血管瘤的治疗,可以获得较好的治疗效果。 Objective To explore the clinical effect of infantile hemangioma by local injection with compound betamethasone preparation (Diprospan ). Methods Twenty-five patients with infantile hemangioma were included in this clinical study. The size of tumors ranged from 1 cm× 1 cm to 8 cm× 8 cm. The ages of patients in the first treatment were from 1 - 7 months old. Injeetive dosage firstly was 1 ml to 2 ml Diprospan diluted with 1 ml to 2 ml aqua pro injectione according to the tumor sizes, injections were performed from the top and margin to the center of tumor with 3 -5 injections. The follow-up interval was 1 month. If hemangioma continued to regress, we just observed it. If hemangioma tended to enlarge again, we made the second injection. All of the follow-up lasted for at least 1 year. Results (1) The hemangioma became soft, flatten and faint at 1 month after treatment. The regression in the central area of tumor was obvious. (2) Some small hemangiomas almost regressed; Some bigger hemangiomas continued regressing which needed to be observed; the other much bigger hemangiomas tended to enlarge again which neened the second injeetion at 2 months after treatment. (3) The regression of most hemangiomas needed one to three times injection from the first visit to 1 year. After two years follow-up, the hemangiomas in some patients looked flat with local telangiectasia, without the local hypertrophy caused by the hyperplasia of fibrofatty tissue. (4) There were no complications except temporal and reversible local atrophy shortly after treatment. Conclusion The local injection of compound betamethasone preparation is a good choice for the small-sized hemangioma. Satisfing results can be acquired with the early treatment.
出处 《中国美容整形外科杂志》 CAS 2009年第5期292-294,共3页 Chinese Journal of Aesthetic and Plastic Surgery
基金 国家自然科学基金资助项目(30700874) 致谢:本临床研究得到上海交通大学医学院附属新华医院整形外科欧阳天祥教授和第二军医大学附属长海医院整形外科邢新教授的指导,在此表示感谢!
关键词 婴幼儿血管瘤 复方倍他米松制剂 注射治疗 Infantile hemangioma Compound betamethasone preparation Local injection
  • 相关文献

参考文献2

二级参考文献19

  • 1邢新,袁斯明,欧阳天祥,陆斌,倪灿荣,杨志勇.Fas/FasL在各阶段婴幼儿血管瘤中的表达及意义[J].中华整形外科杂志,2006,22(2):116-120. 被引量:17
  • 2汪静,汪芳.关于细胞死亡方式的研究进展[J].实用医药杂志,2006,23(10):1250-1252. 被引量:6
  • 3Sarafian V,Dikov D,Kara ivanov M,et al.Differential expression of ABH histo-blood group antigens and LAMPs in infantile hemangioma[J].J Mol Histol,2005,36(8-9):455-460.
  • 4Adams DM,Lucky AW.Cervicofacial vascular anomalies I.Hemangiomas and other benign vascular tumors[J].Semin Pediatr Surg,2006,15(2):124-132.
  • 5North PE,Waner M,Buckmiller L,et al.Vascular tumors of infancy and childhood:Beyond capillary hemangioma[J].Cardiovasc Pathol,2006,15(6):303-317.
  • 6Dyduch G,Okon K,Mierzynski W,et al.Benign vascular proliferations An immunohistochemical and comparative study[J].Pol J Pathol,2004,55(2):59-64.
  • 7Frisher JS,Huang J,Serur A,et al.Biomolecular markers and involution of hemangiomas[J].J Pediatr Surg,2004,39(3):400-404.
  • 8Macini AJ,Smoller BR.Proliferation and apoptosis within juvenile capillary hemangioma[J].Am J Dermatopathol,1996,18:505-514.
  • 9MetryDW.Potentialcomplicationsofsegmentalhemangiomasofinfancy[].SeminCutanMedSurg.2004
  • 10MullikenJB,,BoonLM,TakahashiK, etal.Pharmacologictherapyforendangeringhemangiomas[].CurrOpinDermatol.1995

共引文献15

同被引文献40

  • 1袁斯明,邢新,欧阳天祥,倪灿荣,杨志勇,张敬德.婴幼儿血管瘤病理演变过程中形态观察[J].临床与实验病理学杂志,2005,21(3):290-294. 被引量:15
  • 2林晓曦.血管瘤和血管畸形:经验、进展与挑战[J].中华整形外科杂志,2007,23(2):81-83. 被引量:28
  • 3刘潜,李静,周德凯,李晓庆,唐开勇,金先庆.糖皮质激素瘤内注射治疗婴幼儿血管瘤机理的研究[J].第四军医大学学报,2007,28(13):1199-1201. 被引量:15
  • 4Chiller KG,Passaro D,Frieden IJ.Hemangiomas of infancy:clinical characteristics,morphologic subtypes,and their relationship to race,ethnicity,and sex[J].Arch Dermatol,2002,138(12):1567-1576.
  • 5Lyons LL,North PE,Mac-Moune LF,et al.Kaposiform hemang-ioendothelioma:a study of 33 cases emphasizing its pathologic,immunophenotypic,and biologic uniqueness from juvenile hemangioma[J].Am J Surg Pathol,2004,28(5):559-568.
  • 6Zukerberg LR,Nickoloff BJ,Weiss SW.Kaposiform hemangioen-dothelioma of infancy and childhood; an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis[J].Am J Surg Pathol,1993,7(4):321-328.
  • 7Abass K,Saad H,Kherala M,et al.Successful treatment of Kasabach-Merritt syndrome with vincristine and surgery:a case report and review of literature[J].Cases J,2008,1:9.
  • 8Weiss SW,Goldblum JR.Hemangioendothelioma:vascular tumors of intermediate malignancy // Enzinger and Weiss's soft tissue tumors[M].St.Louis:Mosby,2001,891-915.
  • 9Rodriguez V,Lee A,Witman PM,et al.Kasabach-merritt phenomenon:case series and retrospective review of the mayo clinic experience[J].J Pediatr Hematol Oncol,2009,31(7):522-526.
  • 10López V,Martí N,Pereda C,et al.Successful management of kaposiform hemangioendothelioma with kasabach-merritt phenomenon using vincristine and ticlopidine[J].Pediatr Dermatol,2009,26(3):365-366.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部